Pre-exposure Prophylaxis (PrEP) - Medication Information

A preventative approach where medication is taken before potential exposure to a disease to reduce the risk of infection.
Category
Drug
Where to get
Prescribed by healthcare providers in specific at-risk situations.
Applicable for
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith

Pre-exposure Prophylaxis FAQ


Image credit: aidsnetwork.ca

How effective is pre-exposure prophylaxis?

Pre-exposure prophylaxis (or PrEP) is medicine taken to prevent getting HIV. PrEP is highly effective for preventing HIV when taken as prescribed. PrEP reduces the risk of getting HIV from sex by about 99%. PrEP reduces the risk of getting HIV from injection drug use by at least 74%. PrEP is less effective when not taken as prescribed.

What is PrEP (Pre-exposure prophylaxis)?

PrEP (pre-exposure prophylaxis) is a tablet that reduces the risk of becoming infected with human immunodeficiency virus (HIV). Each PrEP tablet contains two antiretroviral medications – tenofovir and emtricitabine. PrEP can be taken by people who are HIV-negative (do not have HIV) and at risk of HIV exposure.

When do I need post-exposure prophylaxis (PEP)?

If you have had a recent high-risk HIV exposure (within 72 hours) and missed PrEP around the time you had a recent high-risk HIV exposure (within 72 hours) and missed PrEP around the time that the high-risk exposure occurred you may need post-exposure prophylaxis (PEP).

Do I need post-exposure prophylaxis if I have HIV?

If you have had a recent risk of HIV exposure (within 72 hours) you may need post-exposure prophylaxis (PEP) before starting PrEP. PEP is a 28 day course of antiretroviral tablets that may prevent HIV infection. For more information, you can talk to your doctor or nurse or see: GET PEP.

Pre-exposure Prophylaxis References

If you want to know more about Pre-exposure Prophylaxis, consider exploring links below:

Explore Related Topics

What are the challenges associated with long-term use of antiviral agents for HIV?

Examine the challenges that patients may face with prolonged use of antiviral agents for HIV treatment, including drug resistance and adherence issues.

How can healthcare professionals optimize the use of antiviral agents for HIV management?

Discuss strategies that healthcare professionals can employ to optimize the use of antiviral agents for effective HIV management and patient care.